Financial Performance - The net profit attributable to the parent company for Q3 2023 is ¥28,234,524.97, a decrease from ¥30,210,034.33 in the same period last year, representing a decline of approximately 6.5%[16]. - The total comprehensive income for Q3 2023 is ¥28,866,932.94, compared to ¥25,610,221.02 in Q3 2022, indicating an increase of about 12.8%[16]. - The net profit attributable to shareholders decreased by 48.21% in the current reporting period, primarily due to a decline in product gross margin[45]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, decreased by 53.10% year-to-date[45]. - The basic earnings per share for the current reporting period decreased by 50.00% due to the reduction in net profit attributable to shareholders[47]. - The company reported a net profit of approximately RMB 28.87 million for the first three quarters of 2023, compared to RMB 25.61 million in the same period of 2022, an increase of 8.84%[54]. - The net profit attributable to shareholders of the listed company was approximately ¥9.22 million, reflecting a decrease of 48.21% compared to the same period last year[63]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for the year-to-date was approximately ¥6.99 million, down 56.73% year-over-year[63]. - The company reported a decrease in net profit attributable to shareholders of 6.54% for the year-to-date, totaling approximately ¥28.23 million[63]. Assets and Liabilities - As of September 30, 2023, total assets increased by 86.37% to CNY 4,094,592,837.37 compared to CNY 2,196,982,619.19 at the end of 2022[9]. - Total liabilities decreased slightly to CNY 720,249,405.83 from CNY 733,606,683.24, reflecting a strategic focus on debt management[11]. - The total liabilities as of Q3 2023 amount to ¥971,794,653.28, up from ¥921,710,253.75 at the end of the previous year, reflecting an increase of approximately 5.4%[34]. - The non-current liabilities total ¥251,545,247.45, an increase from ¥188,103,570.51, representing a rise of about 33.6%[34]. - Total assets increased by 86.37% at the end of the reporting period, primarily due to the completion of public share issuance in September 2023[45]. Equity - The company’s equity attributable to shareholders increased by 154.56% to CNY 3,041,862,098.58 from CNY 1,194,968,687.90[9]. - The total equity attributable to shareholders of the parent company is ¥3,041,862,098.58, compared to ¥1,194,968,687.90 in the previous year, showing a significant increase[34]. - Shareholders' equity attributable to shareholders increased by 154.56% at the end of the reporting period, resulting from the funds raised through the public offering[45]. Cash Flow - Cash and cash equivalents rose significantly to CNY 1,895,928,687.22 from CNY 351,427,122.58, marking an increase of 438.36%[1]. - The company reported a net cash flow from operating activities of CNY 110,535,646.83, up from CNY 54,453,112.49 in the previous year[12]. - Cash and cash equivalents at the end of the period reached CNY 773,965,328.22, compared to CNY 125,111,417.58 at the end of the previous year[12]. - Operating cash flow increased by 102.99% year-to-date, mainly due to higher operating income and improved collection[45]. Revenue and Costs - Total operating revenue for the first three quarters of 2023 was approximately RMB 648.69 million, up from RMB 576.72 million in the same period of 2022, representing a growth of 12.48%[51]. - Total operating costs for the first three quarters of 2023 were approximately RMB 626.20 million, compared to RMB 536.72 million in the same period of 2022, an increase of 16.66%[51]. - The company's operating revenue for the third quarter of 2023 was approximately ¥234.91 million, representing a year-over-year increase of 3.56%[63]. - The total revenue for the year-to-date reached approximately ¥648.69 million, with a year-over-year increase of 12.48%[63]. Research and Development - Research and development expenses totaled CNY 12,030,221.87, accounting for 5.12% of operating revenue, a decrease of 0.45 percentage points year-over-year[9]. - Research and development expenses for the first three quarters of 2023 were approximately RMB 42.83 million, up from RMB 40.51 million in the same period of 2022, reflecting a growth of 5.71%[52]. Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[6].
中巨芯(688549) - 2023 Q3 - 季度财报